Kiriat Ekron, Israel

Yefet Gamlieli

This inventor holds 2 USPTO granted patents. Top assignee: Teva Medical Ltd.. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yefet Gamlieli. Retrieved from https://idiyas.com/inventor/yefet-gamlieli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Kiryat Ekron, IL (2003)
  • Kiriat Ekron, IL (2004)

Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yefet Gamlieli: Pioneering Inventor from Kiriat Ekron

Introduction: Yefet Gamlieli is a distinguished inventor hailing from Kiriat Ekron, Israel, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yefet Gamlieli holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Yefet Gamlieli has consistently pushed the boundaries of innovation, with a keen focus on developing practical inventions that have the potential to revolutionize industries.

Collaborations: Yefet Gamlieli has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: Yefet Gamlieli's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, leaving a lasting impact on the landscape of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…